Cantor Fitzgerald, L. P. »

Seres Therapeutics shares owned by Cantor Fitzgerald, L. P.

Quarter-by-quarter ownership of Seres Therapeutics (MCRB) shares owned by Cantor Fitzgerald, L. P. from 13F filings

Historical chart of Cantor Fitzgerald, L. P. investment in Seres Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Seres Therapeutics held by Cantor Fitzgerald, L. P. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seres Therapeutics by Cantor Fitzgerald, L. P.

Quarter filed Position value Share count Share price at filing
2024-09-30 $265k 281k 0.95
2023-06-30 $467k 97k 4.79

More positions owned by Cantor Fitzgerald, L. P.

Spdr S&p 500 Etf Tr Put Put Option
Nvidia Corporation Put Put Option
Tesla Put Put Option
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Call Call Option
Tesla Motors (TSLA)
Nvidia Corporation Call Call Option
Gcm Grosvenor Com Cl A (GCMG)
Rumble Com Cl A (RUM)
Tesla Call Call Option
Proshares Tr Ultrapro Qqq (TQQQ)
Super Micro Computer Put Put Option
Broadcom Put Put Option
Super Micro Computer (SMCI)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)

View all positions for Cantor Fitzgerald, L. P.

Top funds holding Seres Therapeutics

Flagship Ventures Management
Vanguard Group
BlackRock
BlackRock
Susquehanna International
Geode Capital Management
Charles Schwab Investment Management
Goldman Sachs Group
Schonfeld Strategic Advisors
Vontobel Holding
Lion Point Capital
State Street Corporation
Citadel Advisors
Verition Fund Management
Cantor Fitzgerald, L. P.

View all funds holding Seres Therapeutics